Concepedia

Michael Binks

MB

26

Publications

1.6K

Citations

20

H-Index

2001

Active since

Affiliations

Pfizer (United States)(Current)

GlaxoSmithKline (United Kingdom)

University of Sheffield

Age UK

Royal Hallamshire Hospital

Michael Binks is an author at Pfizer (United States) specializing in medicine, autoimmune disease, and immunology.

ORCID

Top concepts

Publications per year

2001–2025

26

Publications

26

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

Michael Binks, Jakob Passweg, D E Furst et al. · Annals of the Rheumatic Diseases · 2001 · 285 citations · Full text

Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir

Ravi Shankar Prasad Singh, Sima S. Toussi, Frances Hackman et al. · Clinical Pharmacology & Therapeutics · 2022 · 150 citations · Full text

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony‐stimulating factor

Inmaculada Rioja, Fiona J. Hughes, Catriona Sharp et al. · Arthritis & Rheumatism · 2008 · 138 citations

Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis

Devesh Mewar, Annabel Coote, David Moore et al. · Arthritis Research & Therapy · 2006 · 115 citations · Full text

Association of interleukin‐6 and interleukin‐10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status

Jasmine Healy, Devesh Mewar, David Moore et al. · Arthritis & Rheumatism · 2007 · 83 citations · Full text

Rows per page

1–5 of 26